Piramal Pharma Solutions (PPS), a globally recognized contract development and manufacturing organization (CDMO), is preparing to exhibit its comprehensive suite…
Read More

Piramal Pharma Solutions (PPS), a globally recognized contract development and manufacturing organization (CDMO), is preparing to exhibit its comprehensive suite…
Read More
Tolerance Bio has finalized a high-stakes licensing agreement with Tanabe Pharma, acquiring exclusive worldwide commercialization rights—excluding Japan—for TLB-33, a clinical-stage…
Read More
The most extensive global survey of physicists ever conducted has delivered a startling portrait of an academic discipline grappling with…
Read More
Global pharmaceutical giant Sandoz is undergoing a profound strategic evolution, shifting its long-term commercial anchor away from traditional small-molecule generics…
Read More
The summer of 2026 has officially been recorded as one of the most punishing meteorological events in modern history, characterized…
Read More
A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the…
Read More
The intersection of advanced scientific methodology and visual artistry has once again captured the attention of the global research community…
Read More
The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…
Read More
The largest global survey of physicists ever conducted has exposed profound divisions within the scientific community regarding the most fundamental…
Read More
The quest to fortify the human body against a warming planet has led researchers to a dimly lit room at…
Read More